NEW YORK (AP) _ Progenics Pharmaceuticals Inc. (PGNX) on Wednesday reported a loss of $16.6 million in its second quarter.
The New York-based company said it had a loss of 24 cents per share.
The biopharmaceutical company posted revenue of $2.8 million in the period.
Progenics shares have decreased 30 percent since the beginning of the year. The stock has dropped nearly 5 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PGNX at https://www.zacks.com/ap/PGNX
Keywords: Progenics, Earnings Report